CrushSCI.com
156.3平均天数
131中位天数
41最短天数
501最长天数
3362025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

116 天

European LeukemiaNet clinical signs and symptoms as prognostic markers in polycythemia vera during ruxolitinib

作者
Francesca Palandri; Elena Rossi; Massimo Breccia; Elena M. Elli; Chiara Sartor; Alessandra Dedola; Alessandra Iurlo; Erika Morsia; Novella Pugliese; Roberto Latagliata; Francesco Mendicino; Alessia Tieghi; Giulia Benevolo; Gianni Binotto; Mirko Farina; Alessandra D’Addio; Mario Tiribelli; Daniela Cilloni; Monica Crugnola; Flavia Salvatore; Filippo Branzanti; Daniele Cattaneo; Fabrizio Cavalca; Emilia Scalzulli; Fabrizio Pane; Francesco Lanza; Florian H. Heidel; Giuseppe A. Palumbo; Valerio De Stefano展开收起
作者单位
1. IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy; 2. Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Rome, Italy; 3. Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy; 4. Division of Cellular Biotechnologies and Hematology, University Sapienza, Roma, Italy; 5. Fondazione IRCCS San Gerardo dei Tintori, Divisione di ematologia e unità trapianto di midollo, Monza, Italy; 6. Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy; 7. Hematology Division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; 8. Hematology Unit, Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy; 9. Department of Clinical Medicine and Surgery, Hematology Section, University of Naples “Federico II”, Naples, Italy; 10. Hematology Unit, Ospedale Belcolle, Viterbo, Italy; 11. U.O.C. di Ematologia, Department of Hemato-Oncology, Azienda Ospedaliera Annunziata, Cosenza, Italy; 12. Department of Hematology, Azienda USL—IRCCS di Reggio Emilia, Reggio Emilia, Italy; 13. University Hematology Division, Città della Salute e della Scienza Hospital, Torino, Italy; 14. Unit of Hematology and Clinical Immunology, University of Padova, Padova, Italy; 15. Unit of Blood Diseases and Stem Cells Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy; 16. Division of Hematology, Onco-hematologic Department, AUSL della Romagna, Ravenna, Italy; 17. Division of Hematology and BMT, Department of Medicine, University of Udine, Udine, Italy; 18. Department of Clinical and Biological Sciences, University of Turin, Turin, Italy; 19. Haematology and BMT Centre, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy; 20. Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany; 21. Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate “G.F. Ingrassia”, University of Catania, Catania, Italy展开收起
PDF源文件 DOI 网页
94 天

Genomic and transcriptomic features associated with responses and outcomes of third-generation tyrosine kinase-inhibitor therapy in chronic myeloid leukemia

作者
Xiaoshuai Zhang; Lu Yu; Zongru Li; Yazhen Qin; Yueyun Lai; Robert Peter Gale; Xiaojun Huang; Qian Jiang展开收起
作者单位
1. Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China; 2. Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK; 3. Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China; 4. State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China; 5. Peking University People’s Hospital, Qingdao, China展开收起
PDF源文件 DOI 网页
133 天

Survival trends in Waldenström macroglobulinemia and comparison of outcomes with the general United States population

作者
Muhammad Azeem Khan; Gunjan Gaur; Jithma P. Abeykoon; Morie A. Gertz; Shaji Kumar; Rebecca L. King; Jonas Paludo; Thomas M. Habermann; Ronald S. Go; Joselle Cook; Nadine Abdallah; Gita Thanarajasingam; Francis Buadi; Angela Dispenzieri; Carrie A. Thompson; Wilson Gonsalves; Grzegorz S. Nowakowski; David Dingli; Eli Muchtar; Patricia T. Greipp; Surendra Dasari; Joseph Novak; Rahma Warsame; Thomas E. Witzig; S. Vincent Rajkumar; Stephen M. Ansell; Prashant Kapoor; Saurabh Zanwar展开收起
作者单位
1. Division of Hematology, Mayo Clinic, Rochester, USA; 2. Department of Internal Medicine, Mayo Clinic, Rochester, USA; 3. Division of Hematopathology, Mayo Clinic, Rochester, USA; 4. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, USA展开收起
PDF源文件 DOI 网页
210 天

Differentiation hierarchy in adult B-cell acute lymphoblastic leukemia at clonal resolution

作者
Alec Geßner; Adrien Jolly; Tjeerd P. Sijmonsma; Yves Matthess; Manuel Kaulich; Hui Ming Tew; Stefan Günther; Fabian Lang; Florian Buettner; Michael A. Rieger展开收起
作者单位
1. Department of Medicine 2, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany; 2. German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, a partnership between DKFZ and UCT Frankfurt-Marburg, Frankfurt am Main, Germany; 3. German Cancer Research Center (DKFZ), Heidelberg, Germany; 4. Institute of Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany; 5. Cardio-Pulmonary-Institute, Frankfurt am Main, Germany; 6. Frankfurt Cancer Institute, Frankfurt am Main, Germany; 7. Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany; 8. Department of Medicine and Institute of Informatics, Goethe University Frankfurt, Frankfurt am Main, Germany展开收起
PDF源文件 DOI 网页
131 天

Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML

作者
Camille Aitchedji; Céline Moison; Simon Fortier; Rodrigo Mendoza-Sanchez; Deanne Gracias; Jean-François Spinella; Bounkham Thavonekham; Tara MacRae; Nadine Mayotte; Mélanie Fréchette; Valérie Blouin-Chagnon; Koryne Léveillé; Jalila Chagraoui; Réjean Ruel; Josée Hébert; Anne Marinier; Guy Sauvageau展开收起
作者单位
1. Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada; 2. Division d’Hématologie-Oncologie, Hôpital Maisonneuve-Rosemont, Montréal, Canada; 3. Banque de Cellules Leucémiques du Québec, Hôpital Maisonneuve-Rosemont, Montréal, Canada; 4. Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada; 5. Department of Chemistry, Université de Montréal, Montréal, Canada展开收起
PDF源文件 DOI 网页
501 天

Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML

作者
Ilias Sinanidis; Panagiotis Tsakiroglou; Benjamin Dubner; Rebecca Foertsch; Julia Gondek; InYoung Choi; Bogdan Paun; Teodora Supeanu; Liang Zhao; Gabriel Ghiaur; W. Brian Dalton展开收起
作者单位
1. Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA; 2. Complete Omics Inc, Halethorpe, Baltimore, USA展开收起
PDF源文件 DOI 网页

FAQ

LEUKEMIA审稿要多久?

截至2026-11-18,CrushSCI 收录了 LEUKEMIA 的 20 篇完整审稿记录。最快一篇从收稿到录用用了 41 天(Prof. Richard T Silver—Pioneer of MPN 18 January, 1929–17 April, 2026,2026-04-25 收稿,2026-06-05 录用),最慢一篇用了 501 天;平均 156.3 天,中位数 131 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。